These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16800177)

  • 1. [Cutaneous CD8+ epidermotropic cytotoxic T-cell lymphoma with aggressive course].
    Poszepczynska-Guigné E; Jagou M; Wechsler J; Dieng MT; Revuz J; Bagot M
    Ann Dermatol Venereol; 2006 Mar; 133(3):253-6. PubMed ID: 16800177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Facial ulcerated nodules revealing primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma].
    Rolland M; Dinulescu M; Saillard C; Battistella M; Le Gall F; Lhomme F; Gangneux JP; Dupuy A; Adamski H
    Ann Dermatol Venereol; 2020 Nov; 147(11):764-768. PubMed ID: 32527516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
    Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
    Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Unusual course of CD8+ epidermotropic cutaneous T-cell lymphoma].
    Gardette E; Moguelet P; Barete S; Frances C; Senet P
    Ann Dermatol Venereol; 2016 Dec; 143(12):846-851. PubMed ID: 27161647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vulvar Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma.
    Morse DC; Park KE; Chitsazzadeh V; Li S; Young K; Gunther JR; Dabaja BS; Duvic M
    Int J Gynecol Pathol; 2021 May; 40(3):229-233. PubMed ID: 33741766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aggressive T cytotoxic CD8+ epidermotropic cutaneous lymphoma: a case in a patient with Steinert's myotonic dystrophy].
    Du-Thanh A; Durand L; Costes V; Guillot B; Dereure O
    Ann Dermatol Venereol; 2006 Dec; 133(12):991-4. PubMed ID: 17185931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cutaneous aggressive epidermotropic CD8+ T cell lymphoma with a chronic and indolent course. Is this different from peripheral T cell lymphoma?
    Gomez Vazquez M; Navarra Amayuelas R
    Dermatol Online J; 2012 Mar; 18(3):11. PubMed ID: 22483522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Primary cutaneous aggressive epidermotropic cytotoxic CD8 positive T cell lymphoma: report of one case].
    Intriago B M; Peña O C; Gray H AM; Cabrera C ME; Martínez C V
    Rev Med Chil; 2012 Mar; 140(3):368-72. PubMed ID: 22689119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: proposed diagnostic criteria and therapeutic evaluation.
    Nofal A; Abdel-Mawla MY; Assaf M; Salah E
    J Am Acad Dermatol; 2012 Oct; 67(4):748-59. PubMed ID: 22226429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma with a CD15(+)CD30(-) phenotype.
    Yoshizawa N; Yagi H; Horibe T; Takigawa M; Sugiura M
    Eur J Dermatol; 2007; 17(5):441-2. PubMed ID: 17673391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary Cutaneous CD8+ T-cell Lymphoma, an Indolent and Locally Aggressive Form Mimicking Paronychia.
    Beggs SM; Friedman BJ; Kornreich D; Okon L; Alpdogan O; Shi W; Sahu J
    Am J Dermatopathol; 2018 Apr; 40(4):e52-e56. PubMed ID: 28984695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma clinically simulating pyoderma gangrenosum.
    Wang Y; Li T; Tu P; Wu LS; Zhu XJ
    Clin Exp Dermatol; 2009 Oct; 34(7):e261-2. PubMed ID: 19438529
    [No Abstract]   [Full Text] [Related]  

  • 13. Erythema multiforme-like lesions in primary cutaneous aggressive cytotoxic epidermotropic CD8+ T-cell lymphoma: A diagnostic and therapeutic challenge.
    Tomasini C; Novelli M; Fanoni D; Berti EF
    J Cutan Pathol; 2017 Oct; 44(10):867-873. PubMed ID: 28644551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma with KIR3DL2 and NKp46 expression in a human immunodeficiency virus carrier.
    Karkouche R; Ingen-Housz-Oro S; Le Gouvello S; Charlotte F; Thomas M; Zehou O; Frenkel V; Boutboul D; Chosidow O; Caumes E; Gaulard P; Ortonne N
    J Cutan Pathol; 2015 Mar; 42(3):199-205. PubMed ID: 25407699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare provisional entity: primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma in a young woman.
    Csomor J; Bognár A; Benedek S; Sinkó J; Fekete S; Krenács L; Matolcsy A; Reiniger L
    J Clin Pathol; 2008 Jun; 61(6):770-2. PubMed ID: 18505891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary cutaneous aggressive epidermotropic CD8(+) cytotoxic T-cell lymphoma with atypical presentation.
    Kim SK; Kim YC; Kang HY
    J Dermatol; 2006 Sep; 33(9):632-4. PubMed ID: 16958809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cutaneous CD8+ squamous T-cell bullous lymphoma].
    Héliot-Hosten I; Versapuech J; Vergier B; Taieb A; Delaunay M
    Ann Dermatol Venereol; 2005 Apr; 132(4):359-61. PubMed ID: 15886565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal CD8+ epidermotropic cytotoxic primary cutaneous T-cell lymphoma with multiorgan involvement.
    Marzano AV; Ghislanzoni M; Gianelli U; Caputo R; Alessi E; Berti E
    Dermatology; 2005; 211(3):281-5. PubMed ID: 16205076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid deterioration in a patient with primary aggressive cutaneous epidermotropic CD8+ cytotoxic T-cell ('Berti') lymphoma after administration of adalimumab.
    Jacks SM; Taylor BR; Rogers RP; Ralston JS; Metcalf JS; Lazarchick J
    J Am Acad Dermatol; 2014 Sep; 71(3):e86-7. PubMed ID: 25128139
    [No Abstract]   [Full Text] [Related]  

  • 20. Aggressive epidermotropic cutaneous CD8+ lymphoma: a cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop.
    Robson A; Assaf C; Bagot M; Burg G; Calonje E; Castillo C; Cerroni L; Chimenti N; Dechelotte P; Franck F; Geerts M; Gellrich S; Goodlad J; Kempf W; Knobler R; Massone C; Meijer C; Ortiz P; Petrella T; Pimpinelli N; Roewert J; Russell-Jones R; Santucci M; Steinhoff M; Sterry W; Wechsler J; Whittaker S; Willemze R; Berti E
    Histopathology; 2015 Oct; 67(4):425-41. PubMed ID: 24438036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.